In Brief: Glaxo Wellcome Imitrex
Executive Summary
Glaxo Wellcome Imitrex: Labeling for all formulations of Glaxo's migraine therapy sumatriptan include contraindications and a bold-face warning, not a black box warning, for patients with documented coronary artery disease or who are at risk of developing CAD. The trade name of Glaxo's naratriptan is Amerge ("The Pink Sheet" Sept. 1, T&G-2)...